Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
XGBoost-based model for predicting five-year survival in gastric cancer using clinical indicators
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 25 April 2026

XGBoost-based model for predicting five-year survival in gastric cancer using clinical indicators

  • Yujiao Zhang1 na1,
  • Xuemeng Zhou1 na1,
  • Peixian Li1,
  • Chunfeng Li2 &
  • …
  • Lixia Ke1 

Scientific Reports (2026) Cite this article

  • 836 Accesses

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Biomarkers
  • Cancer
  • Computational biology and bioinformatics
  • Gastroenterology
  • Oncology

Abstract

Accurate diagnosis and prognostic assessment of gastric cancer are critical for improving patient outcomes. The application of advanced machine learning methods, particularly the XGBoost algorithm, offers a promising approach for enhancing prognostic evaluations. In this study, data from 2,270 patients with gastric cancer were analysed to develop a predictive model for prognosis using the XGBoost algorithm and 20 key clinical features. Comprehensive data collection, preprocessing, and feature selection were conducted to ensure robust model construction and validation. The model demonstrated strong predictive performance in the test cohort, achieving an area under the curve (AUC) of 0.855, and it effectively differentiated patients at high-risk from those at low-risk. Feature importance analysis revealed that pTNM stage and CA125 level were the most influential prognostic factors. This study successfully implemented a machine learning-based model integrating the XGBoost algorithm and critical clinical indicators to predict the five-year survival rate of patients with gastric cancer. The findings highlight the potential of such approaches in supporting personalised treatment strategies and advancing cancer prognosis assessment methodologies.

Similar content being viewed by others

Cross-cancer survival prediction using machine learning models

Article Open access 12 March 2026

Comparative study of XGBoost and logistic regression for predicting sarcopenia in postsurgical gastric cancer patients

Article Open access 14 April 2025

Predictive modeling for breast cancer classification in the context of Bangladeshi patients by use of machine learning approach with explainable AI

Article Open access 11 April 2024

Author information

Author notes
  1. Yujiao Zhang and Xuemeng Zhou contributed equally to this work.

Authors and Affiliations

  1. Department of Oncology, Beidahuang Industry Group General Hospital, Harbin, China

    Yujiao Zhang, Xuemeng Zhou, Peixian Li & Lixia Ke

  2. Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin, China

    Chunfeng Li

Authors
  1. Yujiao Zhang
    View author publications

    Search author on:PubMed Google Scholar

  2. Xuemeng Zhou
    View author publications

    Search author on:PubMed Google Scholar

  3. Peixian Li
    View author publications

    Search author on:PubMed Google Scholar

  4. Chunfeng Li
    View author publications

    Search author on:PubMed Google Scholar

  5. Lixia Ke
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Chunfeng Li or Lixia Ke.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Material 1 (download PDF )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y., Zhou, X., Li, P. et al. XGBoost-based model for predicting five-year survival in gastric cancer using clinical indicators. Sci Rep (2026). https://doi.org/10.1038/s41598-026-50043-x

Download citation

  • Received: 26 February 2026

  • Accepted: 18 April 2026

  • Published: 25 April 2026

  • DOI: https://doi.org/10.1038/s41598-026-50043-x

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • gastric cancer
  • prognosis
  • machine learning
  • clinical indicators
  • model
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer